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CASE REPORT
Chromoblastomycosis Caused by Fonsecaea pedrosoi
Dong Min Kim, M.D., Sung Min Hwang, M.D., Moo Kyu Suh, M.D., Gyoung Yim Ha, M.D.
1, 
Gwang Seong Choi, M.D.
2, Jeonghyun Shin, M.D.
2,  Sung Hyub Han, M.D.
2
Departments of Dermatology and 
1Laboratory Medicine, College of Medicine, Dongguk University, Gyeongju, 
2Department of 
Dermatology, College of Medicine, Inha University, Incheon, Korea
We report herein a case of chromoblastomycosis caused by 
Fonsecaea (F.) pedrosoi in a 39-year-old male, who showed 
multiple, asymptomatic, scaly erythematous plaques on the 
left shin for 12 months. Histopathologically, chronic 
granulomatous inflammation and either sclerotic or 
muriform cells were observed. The fungal culture produced 
typical black colonies of F. pedrosoi. The DNA sequence of 
the internal transcribed spacer (ITS) region of the clinical 
sample was 100% match to that of F. pedrosoi IFM 47061 
(GenBank accession number AB240943). The patient was 
treated with 200 mg of itraconazole daily, for 3 months. Skin 
lesions were improved. In Korea, only 9 cases of chro-
moblastomycosis, including this case, have been reported 
until now. The etiologic agent was F. pedrosoi in the majority 
of cases (6/9;67%). The incidence of chromoblastomycosis 
was slightly higher in female, and the upper limbs were more 
affected than the lower limbs in patients. (Ann Dermatol 
23(3) 369∼374, 2011)
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INTRODUCTION
Chromoblastomycosis is a chronic disease caused by 
saprophagous dematiaceous fungi, when it enters through 
an open wound and infects both skin and subcutaneous 
tissue. This disease is mostly reported in tropical and 
subtropical areas and is often caused by Fonsecaea (F.) 
pedrosoi. Other lesser etiologic agents are Cladosporium 
(Cladophialophora) carrionii,  Phialophora verrucosa, 
Rhinocladiella aquaspersa,  F. compacta,  Exophiala (E.) 
dermatitidis, E. jeanselmei and E. spinifera
1-5.
This rare skin disease, caused by fungus profundus, is 
rarely reported in Korea, compared to Japan
4-7, even 
though these two countries are in the same Northeast Asia 
region. In Korea, clinical and histological findings have 
led to diagnosis of this disease by Ahn and Lee
8 in 1990. 
Since the first identification of the etiologic agent by Suh 
et al.
9 in 1996, only 8 cases have been reported
8-15.
Therefore, we present herein the case of a 39-year-old 
male patient who developed multiple erythematous 
plaques on the left lower leg.  Clinical and histo-
pathological findings, as well as fungus culture, light 
microscope findings and molecular biological analysis, 
have led us to diagnose the patient with chromo-
blastomycosis, caused by F. pedrosoi. The findings were 
presented with a review of the literature and previous 
reports of chromoblastomycosis in Korea.
CASE REPORT
A 39-year-old male presented with scaly erythematous 
plaque, with ulceration on the left shin (Fig. 1 and 2). He 
was a Thai worker living in Korea, and without specific 
traumatic event, he had the asymptomatic eythematous 
papule for 12 months. The patient had history of visiting 
Thailand 15 months ago. The lesion gradually increased in 
size and eventually developed into ulcerative erythema-
tous plaque. His past medical history and family history 
was unremarkable. On physical examination, the general 
physical condition was good and there were no specific DM Kim, et al
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Fig. 1. Multiple, scaly erythematous plaques, with ulcers and 
erosions on the left shin.
Fig. 2. Close-up view of the left shin.
Fig. 3. Slow growing, dark brown, velvety colonies on the 
Sabouraud’s dextrose agar slants cultured for 2 weeks, at 25
oC.
Fig. 4. Slow growing, dark brown, mildly heaped, velvety colony
on the Sabouraud’s dextrose agar cultured for 4 weeks, at 25
oC.
Fig. 5. Elliptical, brownish conidia from conidophore were seen
in the slide culture of F. pedrosoi (Lactophenol-cotton blue stain,
×400).
findings, except for the skin lesion. On the visit, laboratory 
studies, including complete blood cell count with 
differentials, peripheral blood smear, liver and renal 
function test, VDRL, urinalysis, stool examination, 
hepatitis viral test, HIV test, chest X-ray, and 
electrocardiogram were all within normal limits or 
negative. KOH mount did not result in finding of any 
etiological agent. However, tissue biopsy conducted by 
culturing the tissue in the Sabouraud’s dextrose slant 
medium showed slow growing, velvet-like, dark brown 
colonies, with slightly elevated center. Same result was 
found with subculture on plate medium (Fig. 3 and 4). 
According to microscopic examination with Lactophenol 
cotton blue staining for hyphae and conidia, conidio-
phores were brown, and ovoid conidia were located 
either at end or at the side of conidiophores (Fig. 5). 
Histopathological examination revealed chronic granulo-Chromoblastomycosis Caused by Fonsecaea pedrosoi
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Fig. 7. Large, dark brown, septate cells, i.e, “sclerotic or muriform
cells”, in the upper dermis (H&E, ×400).
Fig. 8. Alignment of ITS sequences of the sample from the patient and F. pedrosoi IFM47061 (GenBank accession number AB240943).
The sequences of ITS of the clinical samples were 100% match to that of F. pedrosoi IFM 47061 (GenBank accession number AB240943).
ITS: internal transcribed spacer.
Fig. 6. The biopsy specimen showed pseudoepitheliomatous
hyperplasia and chronic granulomatous inflammation (H&E, 
×40).
matous inflammation, with phase disseminated hyper-
plastic, minute abscess and intradermal lymphocytes, 
histiocytes, and giant cells (Fig. 6). Also, large spherical 
thick walled cells formed a cluster (Fig. 7). For Molecular 
biological analysis, DNA was extracted from the cultured 
colonies and the base sequence of ITS was identified. 
Subsequently, using the Blast program, it was compared to 
the base sequence of the reported strain in Thailand 
(stored in GeneBank), i.e. F. pedrosoi IFM 47061 
(GenBank accession number AB240943). The result was a 
100% match (Fig. 8). With clinical, histopathological and 
mycological results, as well as molecular biological 
findings, we were able to diagnose the patient as having 
chromoblastomycosis caused by the strain F. pedrosoi. 
The patient showed clinical improvement to 3 months 
oral administration of itraconazole, 200 mg per day.
DISCUSSION 
Chromoblastomycosis is a chronic fungal disease mostly 
localized in the skin and the subcutaneous tissue. The 
disease is caused by dematiaceous fungi, with commo-
nality of the melanin pigment containing cell wall. The 
infection is through open wound on the skin. Although 
there were some reported cases of animal infection, most 
infections occur in human subjects
16.
This disease is reported in all continents. However, humid 
tropical and subtropical regions of America, Asia and 
Africa had more frequently reported the incidents
1,2 and 
the etiologic agent was most often F. pedrosoi. Other DM Kim, et al
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Table 1. Clinical features in the Korean cases of subcutaneous chromoblastomycosis
Author
(Year) Sex/Age Duration Site Skin lesion Symptom Causative organism Tx
Ahn and Lee
8
 (1990)
Suh et al.
9
 (1996)
Kim et al.
10
 (1997)
Kim et al.
11
 (2000)
Kang et al.
12
 (2002)
Lee et al.
13
 (2003)
Jun et al.
14
 (2004)
Park et al.
15
 (2005)
Present case
 (2010)
M/55
F/58
M/68
F/65
F/56
M/54
F/52
F/37
M/39
1 year
7 months
5 years
2 years
2 years
4 years
6 months
    ․
1 year
Lower leg
Wrist
Dorsum of
 hand
Forearm
Dorsum of
 hands
Thigh
Abdomen
Chest
Lt. shin
Verrucous plaque
Erythematous plaque
Verrucous plaque
Verrucous plaque
Deep ulcer
Erythematous plaque
Verrucous plaque
Erythematous plaque
Erythematous Plaque
Pruritic
Mild 
 pruritic
Asymp-
 tomatic
․
․
Pruritic
․
․
․
․
Fonsecaea pedrosoi
Fonsecaea pedrosoi
Fonsecaea pedrosoi
Fonsecaea pedrosoi
Fonsecaea pedrosoi
Rhinocladiella aquaspersa
Phialophora verrucosa
Fonsecaea pedrosoi
Excision & 
 AMP-B iv
AMP-B
 il inj
ICZ
AMP-B 
 cream
Excision & 
 grafting
TBF
ICZ & 
 excision
AMP-B iv,
 5-flucytosine
ICZ
M: male, F: female, AMP-B: amphotericin B, ICZ: itraconazole, TBF: terbinafine.
etiologic agents are Cladosporium (Cladophialaphora) 
carrionii,  Phialophora verrucosa,  Rhinocladiella aqua-
spersa,  F. compacta,  Exophiala (E.) dermatitidis,  E. 
jeanselmei and E. spinifera
1-5.  The most reported agent 
responsible for incidents in Korea (5 cases
9-13), also was F. 
pedrosoi, followed by Rhinocladiella aquaspersa
14 and 
Phialophora verrucosa
15  (1 case each). 
The disease generally occurs more frequently in males 
then females and all ages can be affected. However, ages 
between 30∼50 and male farmers were most likely to 
develop the disease
1-3,5. The age and sex distribution can 
differ depending on the region. In reported cases in South 
America
17,18, most cases were males of 30∼50 years of 
age. In Japan, however, the incidence of male and female 
was similar and people over 50 were most affected by the 
disease
6. In Korea, the ratio of incidents in regards to sex 
was similar to Japan, in that 4 cases were male and 5 
cases were female (this case included). With regard to age, 
7 out of 9 cases occurred in the age group over 50, which 
is also similar to the trend in Japan, rather than South 
America (Table 1)
8-15. This disease generally manifest itself 
on the lower extremity rather than the upper extremity, 
and the skin rash mostly starts off as red papule and 
gradually takes various forms, such as verrucous nodule or 
plaque
5. In Korea, however, the infection occurred more 
often on the upper extremity rather than the lower 
extremity. The low extremity was infected more in males, 
whereas the upper extremity was more infected in 
females. Clinical manifestations were mostly erythematous 
plaque type or nodular plaque type. This is also similar to 
the case reports from Japan, rather than from South 
America
17,18. Therefore, it seems to be a correlation 
between the geographical region and the incidents. This 
regional discrepancy might derive from differences in the 
level of industrialization and life style.
Histopathologically, chronic granulomatous inflammation, 
with phase disseminated hyperplastic, minute abscess and 
intradermal inflammatory cells were identified. Also 
characteristic, when the massive intradermal cell or 
separation by large spherical thick wall (sclerotic or 
muriform cell) can be seen, then it can be diagnosed as 
Chromoblastomycosis. The sclerotic or muriform cell can 
be observed easily, even in non-stained samples
9,19. In this 
case, the same results were observed.
Mycological opinion was formed from the following 
findings. KOH mount showed the sclerotic cells and tissue 
biopsy conducted by culturing the tissue for a few days in 
the Sabouraud’s dextrose medium, at 25
oC, showed 
development of the dark brown colonies. The microscopic 
examination resulted in identification of 3 types of 
sporulation. First, was the Cladosporium type, where 
conidium is formed, leading to chains. Second, was the 
Rhinocladiella type, where spore is formed at either the 
end or the side of the conidophore. Third, was the 
Phialophora type, where spore is formed at the end of the 
flask type conidophore, named Phialide
2. In this case 
study, the KOH mount did not result in finding of any 
etiologic agent. However, the tissue biopsy conducted by 
culturing the tissue in the Sabouraud’s dextrose medium 
showed slow growing, velvet-like, dark brown colonies, Chromoblastomycosis Caused by Fonsecaea pedrosoi
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with slightly elevated center. According to the micro-
scopic examination, the spores were oval in shape and 
displayed the Cladosporium  type sporulation. Recently, 
De Hoog et al.
20 performed the base sequence and 
phylongenetic analysis of ITS from the nucleus of 
Fonsecaea, and were able to separately identify and name 
F. monophora, apart from F. pedrosoi. Subsequently, they 
classified them into group A, B and C. In 2007, Yaguchi et 
al.
7 performed further base sequence and phylogenetic 
analysis and were able to identify F. pedrosoi. Thus, F. 
monophora, group A was divided into A1 and A2, and the 
B group into B1, B2 and B3, respectively. The A1 group 
was the strain from Thailand, Australia, South America 
and Africa. The A2 group was the strain from Central and 
South America. The B1 group was the strain from Central 
and South America and Africa, B2 was from Japan and 
China and the B3 group was the strain from the United 
States and United Kingdom. In this case study, DNA was 
extracted from the cultured colonies, and the base 
sequence of ITS was identified. Subsequently, using the 
Blast program, it was compared to the base sequence of 
the reported strain in Thailand (stored in GeneBank), i.e. 
F. pedrosoi IFM 47061 (GenBank accession number 
AB240943). The result was 100% match, so it was clear 
that the strain in our patient was from group A1.
The patient in this case was a Thai worker living in Korea 
and the base sequence matched the reported F. pedrosoi 
IFM 47061. This was in accordance with the regional 
distribution findings of Yaguchi et al.
7. With clinical, 
histopathological and mycological results, as well as 
molecular biological findings, we were able to diagnose 
the patient as having chromoblastomycosis by the strain F. 
pedrosoi.
The initial treatment consisted of excision, skin grafting 
and other treatments, such as localized hyperthermia and 
cryosurgery or administering itraconazole, 5-fluorocy-
tosine, or amphotericin B
1-3. Effective treatments usually 
try to prevent the localized recurrence by wide margin 
excision of small or localized lesion areas. However, as in 
our case, too extensively distributed lesions and deep 
infections were not suitable for excision. Thus, in our 
case, we could not perform surgical excision, because of 
extensive distribution of the lesions. The patient showed 
clinical improvement to 3 months oral administration of 
itraconazole.
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